Your session is about to expire
← Back to Search
Beta Blocker
Propranolol Rescue of Prolonged Labor (PROPEL Trial)
Phase 3
Waitlist Available
Led By Lisa Levine, MD, MSCE
Research Sponsored by Lisa Levine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up from start of labor through delivery
Awards & highlights
Pivotal Trial
Summary
This trial found that propranolol given to women in labor can help speed up the process and reduce the likelihood of needing a c-section.
Eligible Conditions
- Prolonged Pregnancy
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ from delivery through hospital discharge, usually 2-4 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~from delivery through hospital discharge, usually 2-4 days
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Mode of Delivery
Secondary study objectives
Chorioamnionitis
Length of Labor
Maternal Morbidity
+2 moreAwards & Highlights
Pivotal Trial
The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: PropranololActive Control1 Intervention
IV Propranolol - 2mg; one possible repeat dose ≥2 hours later
Group II: PlaceboPlacebo Group1 Intervention
Normal saline placebo- 2 mL; one possible repeat dose ≥2 hours later
Find a Location
Who is running the clinical trial?
Lisa LevineLead Sponsor
Lisa Levine, MD, MSCEPrincipal Investigator - University of Pennsylvania
Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Pennsylvania Hospital
1 Previous Clinical Trials
2,300 Total Patients Enrolled